New classifications of gastroesophageal reflux disease: an improvement for patient management?

Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):761-769. doi: 10.1080/17474124.2019.1645596. Epub 2019 Jul 25.

Abstract

Introduction: Gastroesophageal reflux disease (GERD) is a very common and often debilitating disease. In the broad spectrum of GERD phenotypes, three main groups may be traditionally distinguished: 1) patients only affected by esophageal and/or extra-esophageal symptoms; 2) patients with erosive esophagitis and 3) patients with further complications. Areas covered: This review provides an overview on the current classifications of GERD patients, and their impact on their management. Expert opinion: In 2017, the GERD Consensus Working Group focused the attention on patients unresponsive to PPIs. In this scenario, a diagnosis of GERD might be confirmed by evident signs of erosive esophagitis and the finding of pH or multichannel intraluminal impedance-pH tests, such as more than 6%. The 'Lyon Consensus' panel of experts confirmed that positive indices of reflux-symptom association, without other altered parameters, represent reflux hypersensitivity. GERD requires a customized management; it is crucial to assess frequency and severity of symptoms and their response to an optimal course of therapy as well as to explore the endoscopic alterations and consider other diagnoses responsible for persistent symptoms.

Keywords: GERD; NERD; PPIs; lyon consensus; multichannel intraluminal impedance-pH.

Publication types

  • Review

MeSH terms

  • Esophageal pH Monitoring
  • Gastroesophageal Reflux / classification*
  • Gastroesophageal Reflux / diagnosis*
  • Gastroesophageal Reflux / pathology
  • Gastroesophageal Reflux / therapy
  • Humans
  • Proton Pump Inhibitors / therapeutic use

Substances

  • Proton Pump Inhibitors